SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials-Reference-Cited by-同舟云学术

SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials

Published:2022-09 Issue:10354 Volume:400 Page:757-767
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Vaduganathan Muthiah,Docherty Kieran F,Claggett Brian L,Jhund Pardeep S,de Boer Rudolf A,Hernandez Adrian F,Inzucchi Silvio E,Kosiborod Mikhail N,Lam Carolyn S P,Martinez Felipe,Shah Sanjiv J,Desai Akshay S,McMurray John J V,Solomon Scott D

Publisher

Elsevier BV

Subject

General Medicine

Reference25 articles.

1. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure;McDonagh;Eur Heart J,2021

2. 2022 AHA/ACC/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Heidenreich;J Am Coll Cardiol,2022

3. Empagliflozin in heart failure with a preserved ejection fraction;Anker;N Engl J Med,2021

4. Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction;Solomon;N Engl J Med,2022

5. Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction;Butler;Eur Heart J,2022

Cited by 475 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of empagliflozin and dapagliflozin on serum humanin, MOTS-c levels, nitrosative stress, and ferroptosis parameters in diabetic patients with heart failure;European Journal of Pharmacology;2024-11

2. Cardioprotection of Canagliflozin, Dapagliflozin, and Empagliflozin: Lessons from preclinical studies;Chemico-Biological Interactions;2024-11

3. The mechanism and promising therapeutic strategy of diabetic cardiomyopathy dysfunctions: Focus on pyroptosis;Journal of Diabetes and its Complications;2024-10

4. Heart failure with preserved ejection fraction epidemiology, pathophysiology, diagnosis and treatment strategies;International Journal of Cardiology;2024-10

5. The Role of Sodium Glucose Co-Transporter 2 Inhibitors in Atrial Fibrillation: A Comprehensive Review;Journal of Clinical Medicine;2024-09-12